Leyden Labs
Pre-clinicalLeyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.
Founded
2020
Focus
AntibodiesBiologics
About
Leyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.
Funding History
2Total raised: $160M
Series A$140MF-Prime CapitalDec 15, 2021
Seed$20MGVDec 15, 2020
Company Info
TypePrivate
Founded2020
LocationLeiden, Netherlands
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile